Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.530
+0.180 (7.66%)
Feb 6, 2026, 12:16 PM EST - Market open
Genelux Market Cap
Genelux has a market cap or net worth of $112.04 million as of February 6, 2026. Its market cap has increased by 4.29% in one year.
Market Cap
112.04M
Enterprise Value
84.78M
1-Year Change
4.29%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $112.04M, a decrease of -20.93%. That is a compound annual growth rate of -7.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 104.07M | -36.55% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 108.95M |
| Korro Bio | 108.68M |
| MacroGenics | 107.54M |
| Inovio Pharmaceuticals | 107.18M |
| Verrica Pharmaceuticals | 105.69M |
| Coya Therapeutics | 103.64M |
| Dogwood Therapeutics | 101.70M |
| Actuate Therapeutics | 100.41M |